Author(s):
Abhijeet S. Nikam, Avish D. Maru, Yashpal M. More, Avijeet J. Zalte, Vedant B. Kor
Email(s):
abhinikam299@gmail.com
DOI:
10.52711/0975-4377.2024.00021 
Address:
Abhijeet S. Nikam*, Avish D. Maru, Yashpal M. More, Avijeet J. Zalte, Vedant B. Kor
Department of Pharmaceutics, Loknete Dr. J. D. Pawar College of Pharmacy, Manur, Kalwan. Dist. Nashik (M.S.) 423501. India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2024
ABSTRACT:
Loratadine, a histamine H1 receptor antagonist, is used to treat urticaria and allergic rhinitis. Children who have trouble swallowing tablets make it difficult to administer loratadine orally. F1-F9 batches of Loratadine Tablets (ODTs) 10 mg dose were developed and tested in the present research. In this research, super disintegrants such as croscarmellose sodium, sodium starch glycolate, and crosspovidone were used to manufacture fast-dissolving tablets utilising the direct compression method. In phosphate buffer pH 6.8, the impact of various super disintegrants on tablet dissolving behaviour was examined.
Cite this article:
Abhijeet S. Nikam, Avish D. Maru, Yashpal M. More, Avijeet J. Zalte, Vedant B. Kor. Formulation Development and Optimization of Orodispersible Tablet of Loratadine. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(2):133-4. doi: 10.52711/0975-4377.2024.00021
Cite(Electronic):
Abhijeet S. Nikam, Avish D. Maru, Yashpal M. More, Avijeet J. Zalte, Vedant B. Kor. Formulation Development and Optimization of Orodispersible Tablet of Loratadine. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(2):133-4. doi: 10.52711/0975-4377.2024.00021 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-2-2
REFERENCES:
1. Haria M, et al. Loratadine: A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs. 1994; 48: 617–37.
2. Nehal siddiqui M D, Garima G and Pramod Kumar S. A Novel Approach in Oral Fast Dissolving Drug Delivery System and Their Patents. Advances in Biological Research. 2011; 5 (6): 291-303.
3. Kuchekar B S, Atul B C, Mahajan H S. Mouth dissolving tablets: a novel drug delivery system. Pharma Times. 2003; 35: 7- 9.
4. Bhupendra G.Prajapati, Bhaskar Patel. Formulation, Evaluation and Optimization of Orally Disintegrating Tablet of Piroxicam. International Journal of PharmTech Research. 2010: 2(30); 1893- 1899.
5. Bi Y, Sunada H, Yonezawa Y, Dayo K, Otsuka A, Iida K. Preparation and evaluation of compressed tablet rapidly disintegrating in oral cavity. Chem Pharm Bull (Tokyo) 1996; 44: 2121-2127.
6. Bankar GS and Rhodes CT Modern Pharmaceutics, 3rd edition, Marcel Dekker, Inc. New York. 1996: 668-669.
7. Lachman L, Lieberman HA. The theory and practice of Industrial Pharmacy, 3rd edition, Varghese Publishing House, Mumbai. 1991; 67-71: 183-184.
8. Mahajan HS, Patil SB, Gattani SG. Rapidly disintegrating tablets for elderly patients. Pharm Rev. 2005; 3: 49–5.
9. Moffat A.C., Osselton M.D., Widdop B., Clarke’s analysis of drugs and poisons, 3rd edition, Pharmaceutical Press. 2004; 2: 935.
10. Lachman L., Lieberman H.A., and Kanig J.L., The theory and practice of Industrial Pharmacy, 3rd edition, Varghese Publishing House, Mumbai, 1991, 67-71,183-184.
11. Manimaran V., Damodharan N., Mohilal M., Rajkumar K. and Mamachan R.C. Enhancement of Dissolution rate of Glibenclamide by solid Dispersion Technology. Int. J. Curr. Pharm. Res. 2010; 2(3): 14-17.
12. Arora S.C., Sharma P.K., Irchhaiya R. and Khatkar A., Development, characterization and solubility study of solid dispersion of cefpodoxime proxetil by solvent evaporation method, Int. J. ChemTech. Res. 2010; 2(2): 1275-80.
13. Bhise D.S.: ternary solid dispersion of fenofibrate with poloxemer 188 and TPGS for enhancement of solubility and boiavability, Int. J. Res. Pharm. biomed. Sci. 2011; 2(2): 583-95.
14. Kathiresan K., Vijin P., Moorthi C. and Manavalan R.: Formulation and evaluation of loratadine chewable tablets, Res. J. Pharm., biol. Chem. Sci. 2010; 1(4): 764-774.
15. Patel H.A., Patel J.K. and Patel K.N.: Formulation and in vitro evaluation of rapidly disintegrating tablets of loratadine, Int. J. Pharm. Sci. Res. 2010; 1(9): 3.